Ana
Alfonso Piérola

Investigadora Consultora

Foto de Ana

Foto de Irene

Irene
Gañan Gomez

Investigadora

Publicacións nas que colabora con Irene Gañan Gomez (4)

2022

Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy (Nature Medicine, (2022), 28, 3, (557-567), 10.1038/s41591-022-01696-4)
Nature Medicine
Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy
Nature Medicine, Vol. 28, Núm. 3, pp. 557-567

2018

Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms
Oncotarget, Vol. 9, Núm. 11, pp. 9714-9727

2017

Preclinical activity of FF-10501-01, a novel inosine-5′-monophosphate dehydrogenase inhibitor, in acute myeloid leukemia
Leukemia Research, Vol. 59, pp. 85-92